Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [(111)In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron...

por Chan, Conrad, Prozzo, Vanessa, Aghevlian, Sadaf, Reilly, Raymond M.
Publicado 2022

Auger electrons for cancer therapy – a review

por Ku, Anthony, Facca, Valerie J., Cai, Zhongli, Reilly, Raymond M.
Publicado 2019

[(225)Ac]Ac- and [(111)In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-posit...

por Kondo, Misaki, Cai, Zhongli, Chan, Conrad, Forkan, Nubaira, Reilly, Raymond M.
Publicado 2023

Feasibility Evaluation of Radioimmunoguided Surgery of Breast Cancer

por Ravi, Ananth, Reilly, Raymond M., Holloway, Claire M. B., Caldwell, Curtis B.
Publicado 2012

Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, (111)In or β-particle emitting, (177)...

por Aghevlian, Sadaf, Cai, Zhongli, Hedley, David, Winnik, Mitchell A., Reilly, Raymond M.
Publicado 2020

A comparison of (111)In- or (64)Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT

por Chan, Conrad, Scollard, Deborah A, McLarty, Kristin, Smith, Serena, Reilly, Raymond M
Publicado 2011

Estrone-3-Sulphate, a Potential Novel Ligand for Targeting Breast Cancers

por Banerjee, Nilasha, Fonge, Humphrey, Mikhail, Andrew, Reilly, Raymond M., Bendayan, Reina, Allen, Christine
Publicado 2013

A radiolabeled antibody targeting CD123(+) leukemia stem cells – initial radioimmunotherapy studies in NOD/SCID mice engrafted with primary human AML

por Leyton, Jeffrey V., Gao, Catherine, Williams, Brent, Keating, Armand, Minden, Mark, Reilly, Raymond M.
Publicado 2015

Dose predictions for [(177)Lu]Lu-DOTA-panitumumab F(ab′)(2) in NRG mice with HNSCC patient-derived tumour xenografts based on [(64)Cu]Cu-DOTA-panitumumab F(ab′)(2) – implications f...

por Ku, Anthony, Kondo, Misaki, Cai, Zhongli, Meens, Jalna, Li, Min Rong, Ailles, Laurie, Reilly, Raymond M.
Publicado 2021

Development of an Epidermal Growth Factor Derivative with EGFR Blocking Activity

por Panosa, Clara, Tebar, Francesc, Ferrer-Batallé, Montserrat, Fonge, Humphrey, Seno, Masaharu, Reilly, Raymond M., Massaguer, Anna, De Llorens, Rafael
Publicado 2013

CD16(+)NK-92 and anti-CD123 monoclonal antibody prolongs survival in primary human acute myeloid leukemia xenografted mice

por Williams, Brent A., Wang, Xing-Hua, Leyton, Jeffrey V., Maghera, Sonam, Deif, Bishoy, Reilly, Raymond M., Minden, Mark D., Keating, Armand
Publicado 2018